Dyne Therapeutics, Inc. (DYN) Form 8-K Material Events
Dyne Therapeutics, Inc. (DYN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DYN
CIK: 1818794
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerSarah Marsh
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-02 | 4 | 0001193125-26-415584 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001818794-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001972481-26-000280 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001972481-26-000279 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001915598-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-04 | 4 | 0001814189-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | 4 | 0001498428-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001972481-26-000278 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001577014-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001915598-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001814189-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001498428-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 | 0001697616-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001628280-26-057191 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001628280-26-057190 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001628280-26-057188 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001628280-26-056844 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001628280-26-056843 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001628280-26-056842 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001972481-26-000260 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001972481-26-000259 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001972481-26-000258 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001708269-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000206 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001991 | View SEC Doc Filr Page |